Skip to content

Latest News

Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Glenmark Pharmaceuticals recalled 37,200 bottles of Indomethacin capsules and Sun Pharma recalled 2016 bottles of buPROPion Hydrochloride Extended-Release Tablets. Read More ​ Glenmark Pharmaceuticals recalled 37,200 bottles of Indomethacin capsules and Sun Pharma recalled 2016 bottles of buPROPion Hydrochloride Extended-Release Tablets.… Read More »Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

Glenmark Pharmaceuticals recalled 37,200 bottles of Indomethacin capsules and Sun Pharma recalled 2016 bottles of buPROPion Hydrochloride Extended-Release Tablets. Read More ​ Glenmark Pharmaceuticals recalled 37,200 bottles of Indomethacin capsules and Sun Pharma recalled 2016 bottles of buPROPion Hydrochloride Extended-Release Tablets.… Read More »Glenmark, Sun Pharma recall drugs in the US over labelling and manufacturing concerns, confirms USFDA

en_USEnglish